HLA-B*58:01is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HLA-B*58:01is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population
Authors
Keywords
-
Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume 169, Issue 3, Pages 660-665
Publisher
Wiley
Online
2013-04-22
DOI
10.1111/bjd.12389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HLA-B*5801 Should Be Used to Screen for Risk of Stevens-Johnson Syndrome in Family Members of Han Chinese Patients Commencing Allopurinol Therapy
- (2013) M.-H. H. LEE et al. JOURNAL OF RHEUMATOLOGY
- Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA
- (2012) J. Yun et al. ALLERGY
- Prolonged elevation of serum granulysin in drug-induced hypersensitivity syndrome
- (2012) N. Saito et al. BRITISH JOURNAL OF DERMATOLOGY
- Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong
- (2012) M.L.S. Chiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Detection of HLA-B*58:01, the susceptible allele for allopurinol-induced hypersensitivity, by loop-mediated isothermal amplification
- (2012) J. Kwok et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
- (2012) M S Hershfield et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- T-cell receptor and carbamazepine-induced Stevens–Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction
- (2012) Tai-Ming Ko et al. Expert Review of Clinical Immunology
- Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
- (2012) Chun-Yu Wei et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Successful Translation of Pharmacogenetics into the Clinic
- (2012) Elizabeth Phillips et al. Molecular Diagnosis & Therapy
- HLA-B*58:01allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese
- (2012) Zhi-hao Cao et al. PHARMACOGENOMICS
- Severe Cutaneous Reactions Requiring Hospitalization in Allopurinol Initiators: A Population-Based Cohort Study
- (2012) Seoyoung C. Kim et al. ARTHRITIS CARE & RESEARCH
- A Case of Allopurinol-Induced Fixed Drug Eruption Confirmed With a Lymphocyte Transformation Test
- (2012) Min-Hye Kim et al. Allergy Asthma & Immunology Research
- NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions
- (2011) C. Schlapbach et al. ALLERGY
- Drug Hypersensitivity and Human Leukocyte Antigens of the Major Histocompatibility Complex
- (2011) Mandvi Bharadwaj et al. Annual Review of Pharmacology and Toxicology
- Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
- (2011) Ratchadaporn Somkrua et al. BMC Medical Genetics
- Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
- (2011) M Pirmohamed et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Allopurinol hypersensitivity syndrome with acute generalized exanthematous pustulosis manifestations
- (2011) Wan Lin Teo et al. Cutaneous and Ocular Toxicology
- A Recent Update of Pharmacogenomics in Drug-induced Severe Skin Reactions
- (2011) Chun-Yu Wei et al. Drug Metabolism and Pharmacokinetics
- Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?
- (2011) M. H. Lee et al. INTERNAL MEDICINE JOURNAL
- Cutaneous adverse drug reactions to allopurinol: 10 year observational survey of the dermatology department - Cagliari University (Italy)
- (2011) L. Atzori et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency
- (2011) J.-W. Jung et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans
- (2011) Hye-Ryun Kang et al. Pharmacogenetics and Genomics
- Allopurinol pharmacogenetics: assessment of potential clinical usefulness
- (2011) Issam Zineh et al. PHARMACOGENOMICS
- Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity
- (2011) L. Kostenko et al. TISSUE ANTIGENS
- Efficacy and safety of febuxostat in patients with hyperuricemia and gout
- (2011) Ignacio Garcia-Valladares et al. Therapeutic Advances in Musculoskeletal Disease
- Cutaneous adverse drug reactions in a hospital-based Chinese population
- (2010) H.-Y. Huang et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)
- (2010) Felicidade Santiago et al. CONTACT DERMATITIS
- Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population
- (2009) Wichittra Tassaneeyakul et al. Pharmacogenetics and Genomics
- Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity
- (2008) Diana Chessman et al. IMMUNITY
- Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
- (2008) Wen-Hung Chung et al. NATURE MEDICINE
- A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
- (2008) Christine Lonjou et al. Pharmacogenetics and Genomics
- HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis
- (2008) Nahoko Kaniwa et al. PHARMACOGENOMICS
- Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
- (2007) Sima Halevy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started